About ApoCell
ApoCell is a Healthcare company based in Houston (United States) founded in 2004, and was acquired by Precision Medicine Group in October 2018. Provider of clinical trial and clinical development on bioanalytical services. The company has 2,198 employees. Its chief executive, as recorded, is Mark Clein. ApoCell offers products and services including Clinical Trial Management, Lab Services, and Biospecimens. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is Precision Medicine Group, LLC. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.
Company details
ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.
- Headquarters Houston, United States
- Employees 2,198
- Stage Acquired
- SectorsHealthcare
- Website apocell.com
- Social LinkedIn X
- Acquired by Precision Medicine Group (Oct 2018)
- Legal Name Precision Medicine Group, Llc
- InvestorsPrecision Medicine Group
& 1 more
- Employee Count2,198
- Acquired byPrecision Medicine Group
(Oct 2018)
Products & Services of ApoCell
ApoCell offers a comprehensive portfolio of products and services, including Clinical Trial Management, Lab Services, and Biospecimens.
Manages trials for drug development in oncology.
Provides biomarker analysis and immune monitoring.
Supplies tissues and fluids for research purposes.
Funding Insights of ApoCell
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ApoCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2009 | Seed | β | β |
2 investors in total: 2 institutional.
Investors in ApoCell
ApoCell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Precision Medicine Group and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Summit Partners is recognized as a growth equity investment firm. | summitpartners.com | Boston, United States | ||
Provider of clinical research, development, and commercialization services for life sciences | 2012 | precisionmedicinegrp.com | Bethesda, United States |
Investor details for ApoCell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ApoCell
1 people are tracked at ApoCell (1 in leadership); the tracked headcount is 2,198.
| Name | Role | Group |
|---|---|---|
Mark Clein | CEO | Leadership |
Complete people profiles for ApoCell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ApoCell
3 dated milestones of ApoCell across 14 years, from founding to its latest funding, stage changes and deals.
- Founded ApoCell is founded.
- Funding First funding round.
- Exit Acquired by Precision Medicine Group.
Competitors of ApoCell
ApoCell has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | ||
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| eag.com | 1978 | San Diego, United States | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries |
Detailed competitors of ApoCell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ApoCell (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Apocell
Complete news archive for ApoCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ApoCell
ApoCell was founded in 2004 and raised its 1st funding round 5 years after it was founded.
ApoCell is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Mark Clein is the CEO of ApoCell, as recorded in our data.
ApoCell has 2,198 employees.
ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.
ApoCell's top competitors include BioAgilytix, Advion and Evans Analytical Group.
ApoCell offers Clinical Trial Management, Lab Services, and Biospecimens.
ApoCell has 2 investors. Key investors include Precision Medicine Group, and Summit Partners.
ApoCell operates through Precision Medicine Group, Llc.
Yes. ApoCell was acquired by Precision Medicine Group in October 2018.

